Impact of vessel maturation on antiangiogenic therapy in ovarian cancer - Discussion

被引：0
|
作者：
Rubin, Stephen C.
Sood
机构：
来源：
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 2008年 / 198卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Identifying alemtuzumab as an anti-myeloid cell antiangiogenic therapy for the treatment of ovarian cancer
    Heather L Pulaski
    Gregory Spahlinger
    Ines A Silva
    Karen McLean
    Angela S Kueck
    R Kevin Reynolds
    George Coukos
    Jose R Conejo-Garcia
    Ronald J Buckanovich
    Journal of Translational Medicine, 7
  • [42] Identifying alemtuzumab as an anti-myeloid cell antiangiogenic therapy for the treatment of ovarian cancer
    Pulaski, Heather L.
    Spahlinger, Gregory
    Silva, Ines A.
    McLean, Karen
    Kueck, Angela S.
    Reynolds, R. Kevin
    Coukos, George
    Conejo-Garcia, Jose R.
    Buckanovich, Ronald J.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2009, 7
  • [43] Clinical experience with antiangiogenic targeting in ovarian cancer
    Bookman, M. A.
    EJC SUPPLEMENTS, 2009, 7 (02): : 50 - 50
  • [44] Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma (vol 207, pg 491, 2010)
    Helfrich, Iris
    Scheffrahn, Inka
    Bartling, Soenke
    Weis, Joachim
    von Felbert, Verena
    Middleton, Mark
    Kato, Masahi
    Erguen, Sueleyman
    Augustin, Helmut G.
    Schadendorf, Dirk
    JOURNAL OF EXPERIMENTAL MEDICINE, 2013, 210 (04): : 853 - 853
  • [45] Heterogeneity of angiogenesis and blood vessel maturation in human tumors: Implications for antiangiogenic tumor therapies
    Eberhard, A
    Kahlert, S
    Goede, V
    Hemmerlein, B
    Plate, KH
    Augustin, HG
    CANCER RESEARCH, 2000, 60 (05) : 1388 - 1393
  • [46] Antiproliferative, antiangiogenic and proapoptotic actions qualify Nigella sativa as taxane therapy adjuvant in ovarian cancer
    Mathur, Rajani
    Tiwari, Mukesh
    MOLECULAR CANCER RESEARCH, 2016, 14
  • [47] Identification of a Metalloprotease-Chemokine Signaling System in the Ovarian Cancer Microenvironment: Implications for Antiangiogenic Therapy
    Agarwal, Anika
    Tressel, Sarah L.
    Kaimal, Rajani
    Balla, Marianthi
    Lam, Francis H.
    Covic, Lidija
    Kuliopulos, Athan
    CANCER RESEARCH, 2010, 70 (14) : 5880 - 5890
  • [48] Identification of a metalloprotease-chemokine signaling system in the ovarian cancer microenvironment: Implications for antiangiogenic therapy
    Agarwal, Anika
    Tressel, Sarah
    Kaimal, Rajani
    Bala, Marianthi
    Iam, Francis
    Coyle, Lidija
    Kuliopulos, Athan
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [49] Antiangiogenic Therapy with Human Apolipoprotein(a) Kringle V and Paclitaxel in a Human Ovarian Cancer Mouse Model
    Yu, Hyun-Kyung
    Lee, Ho-Jeong
    Yun, Seok-Joong
    Lee, Sun-Joo
    Langley, Robert R.
    Yoon, Yeup
    Yi, Lee S. H.
    Bae, Duk-Soo
    Kim, Jang-Seong
    Kim, Sun Jin
    TRANSLATIONAL ONCOLOGY, 2014, 7 (03): : 368 - 376
  • [50] Antiangiogenic steroids in human cancer therapy
    Pietras, RJ
    Weinberg, OK
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2005, 2 (01) : 49 - 57
12345